120 related articles for article (PubMed ID: 36203318)
1. Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.
Im S; Cho YK; Kang D; Shin GY; Jung ES; Song KY; Lee SH; Park JM
J Gastroenterol Hepatol; 2022 Dec; 37(12):2255-2263. PubMed ID: 36203318
[TBL] [Abstract][Full Text] [Related]
2. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
4. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
Radulović P; Krušlin B
Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
[TBL] [Abstract][Full Text] [Related]
7. Involvement of NEDD9 in the invasion and migration of gastric cancer.
Feng J; Zhao J; Xie H; Yin Y; Luo G; Zhang J; Feng Y; Li Z
Tumour Biol; 2015 May; 36(5):3621-8. PubMed ID: 25577245
[TBL] [Abstract][Full Text] [Related]
8. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
Tikhmyanova N; Golemis EA
PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
[TBL] [Abstract][Full Text] [Related]
9. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases.
Jurčić P; Radulović P; Balja MP; Milošević M; Krušlin B
Oncol Lett; 2019 Mar; 17(3):2881-2889. PubMed ID: 30854064
[TBL] [Abstract][Full Text] [Related]
11. Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.
Lerotić I; Vuković P; Hrabar D; Misir Z; Kruljac I; Pavić T; Forgač J; Ćaćić P; Ulamec M
Bosn J Basic Med Sci; 2021 Oct; 21(5):542-548. PubMed ID: 33485292
[TBL] [Abstract][Full Text] [Related]
12. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Gabbasov R; Xiao F; Howe CG; Bickel LE; O'Brien SW; Benrubi D; Do TV; Zhou Y; Nicolas E; Cai KQ; Litwin S; Seo S; Golemis EA; Connolly DC
Oncogene; 2018 Aug; 37(35):4854-4870. PubMed ID: 29773902
[TBL] [Abstract][Full Text] [Related]
14. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
15. The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.
Sima N; Cheng X; Ye F; Ma D; Xie X; Lü W
PLoS One; 2013; 8(9):e74594. PubMed ID: 24058594
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma.
Zhou S; Xu M; Shen J; Liu X; Chen M; Cai X
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):677-686. PubMed ID: 28578938
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
[TBL] [Abstract][Full Text] [Related]
18. Src kinase determines the dynamic exchange of the docking protein NEDD9 (neural precursor cell expressed developmentally down-regulated gene 9) at focal adhesions.
Bradbury P; Bach CT; Paul A; O'Neill GM
J Biol Chem; 2014 Sep; 289(36):24792-800. PubMed ID: 25059660
[TBL] [Abstract][Full Text] [Related]
19. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
20. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7.
Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S
Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
